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CASE REPORT
Tachycardiomyopathy with familial
predisposition masquerading as peripartum
cardiomyopathy
M. Alings, A. Thornton, M. Scholten, L. Jordaens
A 28-year-old pregnant lady presented with cardio-
myopathy and atrial tachycardia. The patient had
severe heart failure and syncope. Her past medical
history was uneventful. Her mother, however, had
received an implantable cardioverter defibrillator
(ICD) after an out-of-hospital cardiac arrest due to
idiopathic ventricular fibrillation. The patient was
scheduled for programmed stimulation, during
which a monomorphic ventricular tachycardia was
induced. An ICD was then implanted. Following
radiofrequency ablation of the atrial tachycardia,
left ventricular function recovered completely. Given
the family history, a genetic predisposition to both
arrhythmias and tachycardiomyopathy needs to be
considered. (NetdHeartJ2006;14:246-50.)
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A28-year-old, 31-week pregnant, previously healthy
?'iwoman was involved in a car accident following
sudden dizziness with a brief loss of consciousness.
On the scene, paramedics recorded a narrow complex
tachycardia of180 beats/min. Apart from sudden, fast
palpitations with a duration of seconds, her medical
history revealed no abnormalities. In particular, exercise
tolerance had always been normal. The patient's
mother, however, had previously been resuscitated
from nonischaemic, idiopathic ventricular fibrillation,
in the presence of a structural normal heart. She was
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treated with an implantable cardioverter defibrillator
(ICD) and 1-blockers.
On presentation, our patient was not experiencing
palpitations, despite a regular pulse frequency of 140
beats/min. Physical examination showed signs ofmild
right-sided heart failure. Blood pressure was 120/65
mmHg. The ECG showed persistent atrial tachycardia
at 146 beats/min, a horizontal QRS axis in the frontal
plane and clockwise rotation in the horizontal plane,
and normal PR and QRS intervals without signs of
pre-excitation (tachycardia 1). P-wave morphology
suggested sinus tachycardia, which was thought to be
related to decompensated heart failure. Echocardiog-
raphy during tachycardia showed a dilated (LVED 62
mm), poorly contracting left ventricle with global
hypokinesia, and akinesia ofthe interventricular septum
and posterior wall. The ejection fraction was 24%. Left
atrial dimension was 40 mm (PLAX). There was mild
I/IV mitral regurgitation.
There were no signs of foetal distress. A cardio-
tocogram demonstrated normal foetal heart activity.
The patient remained in tachycardia. On telemetry
monitoring, however, asymptomatic episodes of a
second, faster narrow-complex tachycardia with
sudden onset were recorded with a frequency of 185
beats/min (figure 1, tachycardia 2). The ECG dem-
onstrated P-wave morphology similar to that seen in
tachycardia 1 with a P axis of +60°, a positive P wave
in the inferior leads and lead I, and a negative P wave
in lead aVR, consistent with earliest atrial activation
in the high right atrium, near the presumed SA-node
location. PR and QRS duration and repolarisation
were normal.
Carotid sinus massage did not slow or terminate
tachycardia 2. Intravenous administration ofadenosine
caused immediate but temporary cessation of this
tachycardia with temporary resumption of the pre-
existing, presumed, sinus tachycardia, tachycardia 1. On
transition to tachycardia 1, subtle differences in the P-
wave morphology could be distinguished. P-wave
duration increased slightly, and the P-wave axis became
slightly more inferior than during the faster atrial
tachycardia.
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FPfurm 1. 12-ladBCG showing tachyardia 2, at50 mm/sec to more clearly sbow theP waves, whicb arepositive in kads I, II, and IIIand
precede oi QJS comppkls. T71 rate is 195 beats/min. Administration ofadenosine wasfollowed by transition to tacbycardia 1 ata rate of
115 beatl/minwh#rWdC P waves are positive in kad Iand II and isoeketric in III.
The patient intermittently complained ofpalpitations.
During these symptoms, a third narrow complex
tachycardia was recorded with a frequency of 235
beats/min (tachycardia 3). This tachycardia tended to
terninate after short periods. Although P waves could
not dearly be distinguished, the presence of a P wave
was suggested in lead I, with a PR > RP interval. This
tachycardia was reproducibly terminated by administra-
tion ofadenosine intravenously.
As working hypothesis, a tachycardia-induced car-
diomyopathywas postulated, rather than a peripartum
cardiomyopathy. The favourable reaction ofboth atrial
tachycardias to adenosine suggested a cAMP-mediated
substrate. Treatment with metoprolol up to 300
mg/day and digoxin 0.25 mg daily was initiated.
Foetal heart rate was monitored by cardiotocography
and showed no bradycardias. On this therapy the
patient's resting heart rate averaged 110 beats/min
(80 beats/min during sleep to 190 beats/min on mild
exercise). At 37 weeks, an elective caesarean section
was performed and a healthy son was born.
After delivery, the cardiac condition of our patient
remained stable. Tachycardia 1 persisted at rates up to
130 beats/min, despite treatment with metoprolol.
One episode ofnonsustained ventricular tachycardia of
six consecutive beats with R-R intervals of approx-
imately 375 mswas registered. Under P-blockade, only
nonsustained episodes oftachycardia 2 occurred.
The patient was scheduled for programmed elec-
trical stimulation with ablation of the atrial tachy-
cardia(s). During this study under 1-blockade, no
additional supraventricular tachycardias could be
induced and the baseline tachycardia was thought to be
sinus tachycardia based on the activation sequence, and
reactive, based on the underlying poor cardiac function.
Haemodynamically significant sustained monomorphic
ventricular tachycardia, however, was induced using
three long coupled extra-stimuli. Because ofthe positive
family history, documented syncope and inducibility,
a dual-chamber ICD was implanted.
Because ofongoing symptoms ofheart failure and
persistence oftachycardia at a rate of110 to 130 beats/
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Fiure 2. Real-timeposition managment (RPM) anatomic and
activation mapshowing the rightatriumfrm anRAO vww with
earliestactivation in both tachycardia I and2 (assown by the red
area) in the anterolateralpartofthe RA/VCSjunction. RA=ri#bt
atrium, CS=coronarysinus, VCI=inferiorvenacava, VCS=superior
vena cava, SAN=presumed location ofSA node depktedasan ellipse.
min, a new electrophysiology study was performed
after 1-blocker therapywas stopped. During this study,
the patient had a constant atrial tachycardia (tachy-
cardia 1) of 120 to 140 beats/min with paroxysms of
faster rates between 170 and 210 beats/min with the
same activation sequence, presumed to be tachycar-
dia 2. During both tachycardias, activation mapping
showed earliest activation in the high right atrium near
the superior vena cava (figure 2). After radiofrequency
applications in the region ofthe right atrium-superior
vena cava junction, at a site ofvery early atrial activation
(figure 3), atrial tachycardia 2 stopped permanently
(figure 4) and could not be reinduced, not even in the
presence of isoprenaline. No other atrial tachycardias
could be induced. Sinus rhythm at 90 to 105 beats/
min supervened.
Clinical follow-up was favourable. Baseline heart rate
progressively decreased to 60 to 70 beats/min. No
tachycardias recurred, even after reduction of1-blocker
therapy. Holter recordings demonstrated only sinus
rhythm. Echocardiography one month later showed
significant improvement in the ejection fraction and
six months later showed normal left ventricular dimen-
sions with normalised left ventricular function and an
ejection fraction of 53%.
Discuslon
Tachycardia-induced cardiomyopathy was first de-
scribed in 1913,' and experimental tachycardiomyo-
pathy demonstrated in 1962.2 Since then, it has been
associated with multiple sustained atrial and ventricular
Figure 3. Tracing showing earliest activation in the ablation
cather, 62 msbefore theprximalcoronatysinus eectrogramsand
earlier than the onsetofthe Pwave duting tachycardia. The signal
is also broad andfractionated. T7e upper seven tracings arefrom
the surface ECG, followed by the distal and then the proximal
ablation catheter bipolar tracings. Below these are the bipolar
tracingsfrom the coronary sinus, proximal to distal and then the
tracingsfrom the RVcatheter. The tracing is being run ata speed
of400 mm/sec.
tachycardias, as well as with frequent ventricular ectopic
beats.3,4 High rates for sustained periods oftime have
been shown to induce both systolic and diastolic
cardiac dysfunction. The rate predicts to some extent
the degree and rapidity ofonset ofdysfunction.5 Tachy-
cardiomyopathy was originally described as a 'pure'
syndrome with no other underlying cardiac disease,
but it seems that by far the majority of patients are
'impure'. This implies that a primary nonarrhythmic
cardiac disorder is present, and that tachycardias with
poorly controlled rates supervene and exacerbate the
problem.6 It is important to consider tachycardiomyo-
pathy in patients with heart failure, when heart rates
are somewhat higher than the clinical condition would
suggest. Treatment of the underlying tachycardia is
often associated with a rapid, often remarkable, im-
provement in cardiac function.'2 Some patients recover
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Figure 4. Same tracings asfigure 3. After onset of radiofrequency ablation during tachycardia 2 at a rate of195 beats/min, abrupt
tminatinfoUowed by onst ofa slower rhythm at 140 beats/min occur. Thmere is a slightchange in atrial activation sequence.
completely,7 while others improve to a lesser degree.
In the latter, the diagnosis should always be questioned.
The control ofrates in atrial fibrillation has often been
associated with some improvement in function, even
in patients with severe pre-existing nonarrhythmic
disease.8 No dear predisposition has been reported and
no genetic studies have been undertaken to look for a
fimilial association with this syndrome.
Tachycardiomyopathy seems to be associated with
marked dilatation of the cardiac chambers without
associatedhypetohy or an increase in cardiac weight.9
At a cellular level there are changes in both the myocyte
and extracellular matrix.10 The myocytes show changes
in appearance and attachment to the basement
membrane with resultant changes in force coupling, as
well as in myofibril alignment. The extracellular matrix
shows disruption in architecture and this may cause
the changes in myocyte alignment, with resultant
alterations in electrophysiological parameters. The
mechanism has been variously postulated as being due
to myocardial energy depletion, abnormalities in
calcium channelling, myocyte and extracellular re-
modelling, and ischaemia."' However, the last men-
tioned is rarely seen in the 'pure' cases.
Although the presence ofunderlying atrial tachy-
cardias, AV-nodal re-entry tachycardia andAV re-entry
tachycardia has been associated with atrial fibrillation,
in some cases due to underlying tachycardiomyopathy
affecting the atria, there are no previous reports ofthe
incidence ofsecondary ventricular tachyarrhythmias in
patients with a presumptive tachycardiomyopathy.
Heart failure can certainly be associated with ventricular
tachyarrhythmias with the underlying pathophysiology
ofre-entrant versus enhanced automaticity or triggered
activity.'2 Treating heart failure with standard medical
therapy has been shown to decrease the incidence of
ventricular tachycardia.13 In the present case, ICD im-
plantation was performed as well, because ofthe family
history, documented syncope and inducible ventricular
tachycardia at electrophysiology study.
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The family history suggests a genetic predisposition
for development of arrhythmias. In the present case,
restoration ofcardiac function after ablation compared
with lack of improvement in the initial postpartum
peniod tilts the diagnosis towards a tachycardia-induced
cardiomyopathy rather than a genetic predisposition for
development of peripartum cardiomyopathy. There-
fore, the association with sudden death in the family
suggests the presence of a primary electrical disease
which was hidden until now.
The ECG of our patient during sinus rhythm
showed normal conduction intervals and repolarisation,
and the QT intervals were normal. Her mother's
resting ECG, however, was abnormal: the inferolateral
leads showed negative T waves and the QT interval
was short, ranging from 280 msec (108 beats/min) to
320 msec (75 beats/min) (QTc(B,) 375 and 357 msec,
respectively).
The ECG ofour patient's sister, which was being
analysed elsewhere for palpitations, showed similar
repolarisation abnormalities in the inferolateral leads,
with QT intervals ranging from 280 msec (83 beats/
min) to 310 msec (105 beats/min) (QTC(B) 329 and
410 msec, respectively). In both mother and sister,
however, tall narrow positive T waves in the precordial
leads were absent.
These ECGs are not characteristic for commonly
known primary electrical diseases. Although the QT
intervals were relatively short, an underlying short-QT
syndrome (SQTS) seems unlikely. SQTS, which has
recently been recognised as a risk factor for sudden
cardiac death, is characterised by even shorter QT
intervals, typically QTC(B)< 320 msec, and short ST
segments followed by tall and narrow T waves in the
precordial leads.'4
The observed restoration of the tachycardiomyo-
pathy in our patient raised the question whether, on
depletion, ICD generator replacement will be necessary.
However, the observation that two and three years later,
with complete restoration ofLV function, asymptom-
atic nonsustained VTs of ten beats, cycle length 225
and 300 msec respectively, were registered in the ICD
log, suggests that familial predisposition does play a
role in the arrhythmogenesis in this patient. -
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